Related Experiment Video
Updated: Jul 9, 2026
08:04
Preparation of Functional Silica Using a Bioinspired Method
Published on: August 1, 2018
Mixed micelle-template route to mesoporous silica
You-Hwan Son1, Man Park, Sang Tae Kim
1Center for Intelligent Nano-Bio Materials (CINBM), Division of Nanoscience and Department of Chemistry, Ewha Womans University, Seoul 120-750, Korea.
Journal of Nanoscience and Nanotechnology
|December 1, 2007
Summary
Researchers developed a new mesoporous silica material using a mixed micelle-template method. This novel drug delivery system effectively encapsulates C2-ceramide, inducing apoptosis in cancer cells.
Area of Science:
- Materials Science
- Nanotechnology
- Biomedical Engineering
Background:
- Mesoporous silica materials offer potential for drug delivery due to their high surface area and tunable pore sizes.
- Ceramides, like C2-ceramide, are bioactive lipids with potential therapeutic applications, including anti-cancer effects.
- Developing efficient methods to encapsulate and deliver therapeutic agents within mesoporous structures is crucial for their clinical translation.
Purpose of the Study:
- To synthesize mesoporous silica materials using a novel mixed micelle-template method.
- To investigate the structural integrity of the mesoporous silica after encapsulating C2-ceramide.
- To evaluate the in vitro anti-cancer efficacy of the C2-ceramide-loaded mesoporous silica.
Main Methods:
- Preparation of mesoporous silica using alkyl polyethylene oxide (C16E20) and C2-ceramide as a mixed micelle-template.
- Characterization of the mesoporous silica structure using X-ray diffraction (XRD), Transmission Electron Microscopy (TEM), and N2 adsorption-desorption isotherms.
- In vitro apoptosis assays on cancer cell lines (MCF-7, HOS, HepG2) treated with C2-ceramide-encapsulated mesoporous silica.
Main Results:
- Mesoporous silica formation was confirmed by XRD, TEM, and N2 adsorption, particularly at C16E20/C2-ceramide weight ratios up to 3/1.
- The mesoporous structure remained intact after C2-ceramide encapsulation, although higher ratios (exceeding 2/2) led to less ordered pores.
- In vitro studies demonstrated that simultaneously encapsulated C2-ceramide induced apoptosis in MCF-7, HOS, and HepG2 cancer cells.
Conclusions:
- A novel mixed micelle-template method successfully produced mesoporous silica materials suitable for drug delivery.
- The developed material effectively encapsulates C2-ceramide while maintaining structural integrity.
- The C2-ceramide-loaded mesoporous silica exhibits promising in vitro anti-cancer activity, suggesting its potential as a drug delivery system.
